Insider trades
Patrick D. Yeramian, Chief Officer of Amylyx Pharmaceuticals AMLX, has filed 0 purchases and 10 sales on the open market. The latest trade was on 24/01/09.
Patrick D. Yeramian
Chief Medical Officer
- Company
- Amylyx Pharmaceuticals AMLX
- First filing
- 23/01/10
- Trades
- 28 trades
- Buys / sales
- 0 / 10
- 12-month net buying
- No record
- Last trade
- 24/01/09
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 24/01/09 | 24/01/11 | 2,812 sh | $16.33 | $45,919.96 | −1.3% | |
| Open-market sale10b5-1 plan | 23/05/15 | 23/05/17 | 11,965 sh | $29.03 | $347,343.95 | −5.4% | |
AMLX | Open-market sale10b5-1 plan | 23/04/17 | 23/04/19 | 49,579 sh2 trades | $30.53avg. | $1,513,769.87 | −19.2% |
AMLX | Open-market saleAmendment | 23/03/16 | 23/03/24 | 54,627 sh2 trades | $31.88avg. | $1,741,271.23 | −21.5% |
AMLX | Open-market sale | 23/03/16 | 23/03/20 | 54,627 sh2 trades | $31.88avg. | $1,741,271.23 | −26.7% |
AMLX | Open-market sale | 23/01/06 | 23/01/10 | 2,034 sh2 trades | $36.30avg. | $73,833.31 | +1.0% |